These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35458667)

  • 1. Molecular Modeling and Experimental Evaluation of Non-Chiral Components of Bergamot Essential Oil with Inhibitory Activity against Human Monoamine Oxidases.
    Catalano R; Procopio F; Chavarria D; Benfeito S; Alcaro S; Borges F; Ortuso F
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor.
    Zarmouh NO; Eyunni SK; Soliman KF
    BMC Complement Altern Med; 2017 Jan; 17(1):34. PubMed ID: 28069007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the inhibitory effects of eckol and dieckol isolated from edible brown alga Eisenia bicyclis on human monoamine oxidases A and B.
    Jung HA; Roy A; Jung JH; Choi JS
    Arch Pharm Res; 2017 Apr; 40(4):480-491. PubMed ID: 28251489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer's Disease.
    Reeta ; Baek SC; Lee JP; Rangarajan TM; Ayushee ; Singh RP; Singh M; Mangiatordi GF; Nicolotti O; Kim H; Mathew B
    CNS Neurol Disord Drug Targets; 2019; 18(8):643-654. PubMed ID: 31550216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson's disease: Synthesis, biochemistry, and molecular dynamics study.
    Thomas Parambi DG; Oh JM; Kumar S; Sudevan ST; Hendawy OM; Abdelgawad MA; Musa A; Al-Sanea MM; Ahmad I; Patel H; Kim H; Mathew B
    Comput Biol Chem; 2023 Aug; 105():107899. PubMed ID: 37315342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent and selective inhibition of human monoamine oxidase-B by 4-dimethylaminochalcone and selected chalcone derivatives.
    Oh JM; Kang MG; Hong A; Park JE; Kim SH; Lee JP; Baek SC; Park D; Nam SJ; Cho ML; Kim H
    Int J Biol Macromol; 2019 Sep; 137():426-432. PubMed ID: 31271801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Umbelliferone derivatives exert neuroprotective effects by inhibiting monoamine oxidase A, self-amyloidβ aggregation, and lipid peroxidation.
    Seong SH; Ali MY; Jung HA; Choi JS
    Bioorg Chem; 2019 Nov; 92():103293. PubMed ID: 31557622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric synthesis, molecular modeling and biological evaluation of 5-methyl-3-aryloxazolidine-2,4-dione enantiomers as monoamine oxidase (MAO) inhibitors.
    Erol Gunal S; Teke Tuncel S; Gokhan Kelekci N; Ucar G; Yuce Dursun B; Sag Erdem S; Dogan I
    Bioorg Chem; 2018 Apr; 77():608-618. PubMed ID: 29501028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine oxidase A and B inhibitory activities of 3,5-diphenyl-1,2,4-triazole substituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives.
    Bekircan O; Danış Ö; Şahin ME; Çetin M
    Bioorg Chem; 2022 Jan; 118():105493. PubMed ID: 34814086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavonoids from Sideritis Species: Human Monoamine Oxidase (hMAO) Inhibitory Activities, Molecular Docking Studies and Crystal Structure of Xanthomicrol.
    Turkmenoglu FP; Baysal İ; Ciftci-Yabanoglu S; Yelekci K; Temel H; Paşa S; Ezer N; Çalış İ; Ucar G
    Molecules; 2015 Apr; 20(5):7454-73. PubMed ID: 25915461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action.
    Elkamhawy A; Kim HJ; Elsherbeny MH; Paik S; Park JH; Gotina L; Abdellattif MH; Gouda NA; Cho J; Lee K; Nim Pae A; Park KD; Roh EJ
    Bioorg Chem; 2021 Nov; 116():105352. PubMed ID: 34562673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors.
    Tzvetkov NT; Stammler HG; Neumann B; Hristova S; Antonov L; Gastreich M
    Eur J Med Chem; 2017 Feb; 127():470-492. PubMed ID: 28107736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing Multi-Target Action of Phlorotannins as New Monoamine Oxidase Inhibitors and Dopaminergic Receptor Modulators with the Potential for Treatment of Neuronal Disorders.
    Seong SH; Paudel P; Choi JW; Ahn DH; Nam TJ; Jung HA; Choi JS
    Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31238535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rational approach to elucidate human monoamine oxidase molecular selectivity.
    Mangiatordi GF; Alberga D; Pisani L; Gadaleta D; Trisciuzzi D; Farina R; Carotti A; Lattanzi G; Catto M; Nicolotti O
    Eur J Pharm Sci; 2017 Apr; 101():90-99. PubMed ID: 28188911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, in vitro, and in silico studies of new derivatives of diphenylpiperazine scaffold: A key substructure for MAO inhibition.
    El-Halaby LO; El-Husseiny WM; El-Messery SM; Goda FE
    Bioorg Chem; 2024 Feb; 143():107011. PubMed ID: 38061181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent and Selective Monoamine Oxidase-B Inhibitory Activity: Fluoro- vs. Trifluoromethyl-4-hydroxylated Chalcone Derivatives.
    Mathew B; Mathew GE; Uçar G; Baysal I; Suresh J; Mathew S; Haridas A; Jayaprakash V
    Chem Biodivers; 2016 Aug; 13(8):1046-52. PubMed ID: 27402375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel C7-Substituted Coumarins as Selective Monoamine Oxidase Inhibitors: Discovery, Synthesis and Theoretical Simulation.
    Wang D; Hong RY; Guo M; Liu Y; Chen N; Li X; Kong DX
    Molecules; 2019 Nov; 24(21):. PubMed ID: 31694262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies.
    Elkamhawy A; Paik S; Park JH; Kim HJ; Hassan AHE; Lee K; Park KD; Roh EJ
    Bioorg Chem; 2021 Oct; 115():105233. PubMed ID: 34390968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine Oxidase Inhibitory Activity: Methyl- versus Chlorochalcone Derivatives.
    Mathew B; Uçar G; Mathew GE; Mathew S; Kalatharakkal Purapurath P; Moolayil F; Mohan S; Varghese Gupta S
    ChemMedChem; 2016 Dec; 11(24):2649-2655. PubMed ID: 27902880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chalcones: a valid scaffold for monoamine oxidases inhibitors.
    Chimenti F; Fioravanti R; Bolasco A; Chimenti P; Secci D; Rossi F; Yáñez M; Orallo F; Ortuso F; Alcaro S
    J Med Chem; 2009 May; 52(9):2818-24. PubMed ID: 19378991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.